Panagiotis Tsourapas Sells 35,000 Shares of Colgate-Palmolive (NYSE:CL) Stock

Colgate-Palmolive Company (NYSE:CL) COO Panagiotis Tsourapas sold 35,000 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total value of $3,311,350.00. Following the completion of the transaction, the chief operating officer owned 10,415 shares in the company, valued at $985,363.15. This represents a 77.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Panagiotis Tsourapas also recently made the following trade(s):

• On Thursday, February 12th, Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00.

Colgate-Palmolive Stock Performance

Shares of CL opened at $96.61 on Friday. The firm has a market cap of $77.87 billion, a price-to-earnings ratio of 36.87, a price-to-earnings-growth ratio of 4.36 and a beta of 0.29. The company’s fifty day moving average is $83.80 and its 200-day moving average is $81.87. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.91 earnings per share. Equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CL. Evercore increased their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, February 2nd. Wells Fargo & Company raised their target price on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a research note on Sunday, February 1st. Rothschild & Co Redburn set a $93.00 target price on shares of Colgate-Palmolive in a research report on Friday. Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Finally, Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $94.38.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CL. Westside Investment Management Inc. grew its position in Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after buying an additional 130 shares in the last quarter. CBIZ Investment Advisory Services LLC lifted its position in shares of Colgate-Palmolive by 86.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after acquiring an additional 150 shares during the period. Triumph Capital Management grew its holdings in shares of Colgate-Palmolive by 62.9% during the 4th quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after purchasing an additional 127 shares in the last quarter. Jessup Wealth Management Inc bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $26,000. Finally, Maseco LLP acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at $27,000. Institutional investors own 80.41% of the company’s stock.

Key Stories Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Jim Cramer highlighted Colgate’s strong growth on his show, a high-visibility endorsement that can boost investor sentiment and trading interest. Colgate (CL) had great growth, says Jim Cramer
• Positive Sentiment: Zacks Research raised several near‑term and longer‑term EPS estimates (including FY2026, FY2027 and Q4 updates) — a signal of improving analyst expectations that supports the stock’s upside. Market summary with Zacks note: Colgate-Palmolive (CL) — MarketBeat summary
• Positive Sentiment: Recent quarterly results beat estimates (Q4 EPS and revenue topped consensus) and the company recently paid its regular quarterly dividend — both reinforce Colgate’s cash-generation and income-profile that investors prize in staples. Full company/analyst roundup: Colgate-Palmolive (CL) — MarketBeat summary
• Neutral Sentiment: Zacks issued a mix of small raises and cuts across individual quarters (some Q1–Q3 2026/2027 estimates were trimmed while other quarters were nudged higher). The net effect is modest — watch upcoming quarterly cadence rather than reacting to isolated quarter tweaks. Source: MarketBeat/Zacks summary: Colgate-Palmolive (CL) — MarketBeat summary
• Negative Sentiment: Significant insider selling by the COO, Panagiotis Tsourapas — 35,000 shares sold Feb. 11 and another 15,000 on Feb. 12 (disclosures show a large reduction in his holdings). Large exec sales can be perceived negatively by investors even if they’re for diversification or liquidity reasons. Colgate-Palmolive (NYSE:CL) COO Sells $1,467,150.00 in Stock
• Negative Sentiment: Another insider (John Hazlin) recently sold ~20,989 shares; multiple insider sales in a short span increase perceived governance/insider-conviction risk. SEC filing and trade details: SEC Filing — Insider Sales

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.